Drug class in one race
PCSK9 drugs for Atherosclerotic Cardiovascular Disease
19 tracked PCSK9 drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the PCSK9 page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
3 approved / phase 49 Phase 33 Phase 24 Phase 1
Head-to-head evidence: AZD0780 vs AZD8233 · Alirocumab vs AZD0780 · AZD0780 vs COR-1004 · AZD0780 vs DNV001 · AZD0780 vs Ebronucimab · AZD0780 vs Enlicitide